Quick take: Pharmaceutical stocks dominate gainers list


KUALA LUMPUR: Pharmaceutical stocks are in the spotlight in early trade Wednesday, dominating the gainers’ list on Bursa Malaysia.

Pharmaceutical companies across the world have been working on developing a Covid-19 vaccine.

Pharmaniaga, the top gainer on Bursa Malaysia surged 99 sen to RM4.49, its highest since December 2017.

Duopharma added 64 sen to RM2.92, Kotra Industries rose 53 sen to RM3.28, Apex Healthcare Bhd gained 52 sen to RM3.58 and Y.S.P Southeast Asia rose 26 sen to RM2.69

Last week, Science, Technology and Innovation Minister Khairy Jamaluddin said that Pharmaniaga and Duopharma would undertake the fill and finish processes for the Covid-19 vaccine, once it is developed.

Khairy said Prime Minister Tan Sri Muhyiddin Yassin had agreed for the facilities of the two companies to be utilised for the purpose, noting that the main challenge for the production of the vaccine was the finishing process.

"We will be purchasing the vaccine overseas, either from China, the US or the UK, in bulk, and we will be doing the bottling process here," Khairy said.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3

Pharmaniaga , Duopharma , covid-19 , Pharmaceutical

   

Did you find this article insightful?

Yes
No

100% readers found this article insightful

Next In Business News

Maybank’s 9M core net profit within CGS-CIMB Research’s forecast
RHB Research keeps Buy call on Public Bank, TP RM21.60
Ringgit opens higher on continued dollar weakness
China's factory activity expands at fastest pace in over 3 yrs
Bursa ekes out slight gains, China data to boost sentiment
Foreign selling on Bursa at RM23.48bil since January
Padini poised for further recovery, says Kenanga
Trading ideas: Public Bank, Padini, Axiata, Hong Leong Bank, Greatech
Kenanga raises earnings outlook on Axiata
Britain bans new Huawei 5G kit installation from September 2021

Stories You'll Enjoy